Kaveh Zakeri

TitleResident Physician
InstitutionUniversity of California San Diego
DepartmentRadiation Medicine and Applied Science
Address9500 Gilman Drive #0843
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bryant AK, Sojourner EJ, Vitzthum LK, Zakeri K, Shen H, Nguyen C, Murphy JD, Califano JA, Cohen EEW, Mell LK. Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer. J Natl Cancer Inst. 2018 Jun 05. PMID: 29878161.
      View in: PubMed
    2. Zakeri K, Coleman CN, Vikram B. Radiation Oncology in the 21st Century: Prospective Randomized Trials That Changed Practice… or Didn't! Front Oncol. 2018; 8:130. PMID: 29761073.
      View in: PubMed
    3. Tringale KR, Carroll KT, Zakeri K, Sacco AG, Barnachea L, Murphy JD. Cost-effectiveness Analysis of Nivolumab for Treatment of Platinum-Resistant Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. J Natl Cancer Inst. 2017 Nov 03. PMID: 29126314.
      View in: PubMed
    4. Mell LK, Brumund KT, Daniels GA, Advani SJ, Zakeri K, Wright ME, Onyeama SJ, Weisman RA, Sanghvi PR, Martin PJ, Szalay AA. Phase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma. Clin Cancer Res. 2017 Oct 01; 23(19):5696-5702. PMID: 28679776.
      View in: PubMed
    5. Chen VE, Gillespie EF, Zakeri K, Murphy JD, Yashar CM, Lu S, Einck JP. Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer. Adv Radiat Oncol. 2017 Apr-Jun; 2(2):105-109. PMID: 28740920.
      View in: PubMed
    6. Green G, Carmona R, Zakeri K, Lee CH, Borgan S, Marhoon Z, Sharabi A, Mell LK. Specificity of Genetic Biomarker Studies in Cancer Research: A Systematic Review. PLoS One. 2016; 11(7):e0156489. PMID: 27383192; PMCID: PMC4934683.
    7. Carmona R, Zakeri K, Green G, Hwang L, Gulaya S, Xu B, Verma R, Williamson CW, Triplett DP, Rose BS, Shen H, Vaida F, Murphy JD, Mell LK. Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events. J Clin Oncol. 2016 Apr 10; 34(11):1270-7. PMID: 26884579.
      View in: PubMed
    8. Zakeri K, Oganesyan G, Lee RA, Lillis JV. Erythema induratum of Bazin presenting as peripheral neuropathy. Cutis. 2015 Sep; 96(3):E1-4. PMID: 26562274.
      View in: PubMed
    9. Lau SK, Zakeri K, Zhao X, Carmona R, Knipprath E, Simpson DR, Nath SK, Kim GY, Sanghvi P, Hattangadi-Gluth JA, Chen CC, Murphy KT. Single-Isocenter Frameless Volumetric Modulated Arc Radiosurgery for Multiple Intracranial Metastases. Neurosurgery. 2015 Aug; 77(2):233-40; discussion 240. PMID: 25856109; PMCID: PMC4506233.
    10. Mell LK, Zakeri K. Underrepresentation of Local Therapy Trials in Leading Medical Journals: Cause for Outrage or Indifference? Int J Radiat Oncol Biol Phys. 2015 Jul 15; 92(4):732-4. PMID: 26104928.
      View in: PubMed
    11. Zakeri K, Rose BS, D'Amico AV, Jeong JH, Mell LK. Competing events and costs of clinical trials: Analysis of a randomized trial in prostate cancer. Radiother Oncol. 2015 Apr; 115(1):114-9. PMID: 25857696.
      View in: PubMed
    12. Zhu H, Zakeri K, Vaida F, Carmona R, Dadachanji KK, Bair R, Aydogan B, Hasan Y, Yashar CM, Mell LK. Longitudinal study of acute haematologic toxicity in cervical cancer patients treated with chemoradiotherapy. J Med Imaging Radiat Oncol. 2015 Jun; 59(3):386-93; quiz 394. PMID: 25828068.
      View in: PubMed
    13. Mell LK, Zakeri K, Rose BS. On lumping, splitting, and the nosology of clinical trial populations and end points. J Clin Oncol. 2014 Apr 01; 32(10):1089-90. PMID: 24550413.
      View in: PubMed
    14. Zakeri K, MacEwan I, Vazirnia A, Cohen EE, Spiotto MT, Haraf DJ, Vokes EE, Weichselbaum RR, Mell LK. Race and competing mortality in advanced head and neck cancer. Oral Oncol. 2014 Jan; 50(1):40-4. PMID: 24134948.
      View in: PubMed
    15. Zakeri K, Rose BS, Gulaya S, D'Amico AV, Mell LK. Competing event risk stratification may improve the design and efficiency of clinical trials: secondary analysis of SWOG 8794. Contemp Clin Trials. 2013 Jan; 34(1):74-9. PMID: 23063467; PMCID: PMC3525784.
    Kaveh's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.